IDEAS home Printed from https://ideas.repec.org/a/taf/eurjdr/v19y2007i1p49-65.html
   My bibliography  Save this article

The Gap Between Successful Innovation and Access to its Benefits: Indian Pharmaceuticals

Author

Listed:
  • Sudip Chaudhuri

Abstract

This article examines a paradox. India has received worldwide recognition as a low-cost producer of high-quality drugs. This has contributed to accessibility of drugs abroad and reflects strong innovative capabilities developed in India. Yet at home, most Indian people do not have regular access to essential medicines. The contrast between the success of Indian industrial policy in developing the industry and the failure of Indian health policy in ensuring access to drugs demonstrates starkly the need for integration of industrial and health policies if safe universal access to essential medicines is to be achieved. Cet article analyse un paradoxe. L'Inde est connue pour sa capacité à produire des médicaments de bonne qualité à bas prix. Cela a contribué à rendre ces produits plus accessibles aux populations de différents pays. Cependant, les populations indiennes ont des difficultés à accéder aux médicaments essentiels. Le contraste entre l'agressivité de la politiqueindustrielle et l'incapacité des services de santé à fournir un accès équitable aux médicaments montre le besoin d'intégrer ces deux dimensions si l'on veut plus d'équité en matière d'accès aux soins.

Suggested Citation

  • Sudip Chaudhuri, 2007. "The Gap Between Successful Innovation and Access to its Benefits: Indian Pharmaceuticals," The European Journal of Development Research, Taylor and Francis Journals, vol. 19(1), pages 49-65.
    • Handle: RePEc:taf:eurjdr:v:19:y:2007:i:1:p:49-65
    DOI: 10.1080/09578810601144293
    as

    Download full text from publisher

    File URL: http://www.informaworld.com/openurl?genre=article&doi=10.1080/09578810601144293&magic=repec&7C&7C8674ECAB8BB840C6AD35DC6213A474B5
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1080/09578810601144293?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Schüren Verena, 2013. "What a difference a state makes: pharmaceutical innovation after the TRIPs agreement," Business and Politics, De Gruyter, vol. 15(2), pages 217-243, August.
    2. Lockhart, Michelle & Babar, Zaheer Ud-Din & Garg, Sanjay, 2010. "Evaluation of policies to support drug development in New Zealand," Health Policy, Elsevier, vol. 96(2), pages 108-117, July.
    3. Thomas Eimer & Susanne Lütz, 2010. "Developmental states, civil society, and public health: Patent regulation for HIV/AIDS pharmaceuticals in India and Brazil," Regulation & Governance, John Wiley & Sons, vol. 4(2), pages 135-153, June.
    4. Hu, Mei-Chih & Hung, Shih-Chang, 2014. "Taiwan's pharmaceuticals: A failure of the sectoral system of innovation?," Technological Forecasting and Social Change, Elsevier, vol. 88(C), pages 162-176.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:eurjdr:v:19:y:2007:i:1:p:49-65. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/FEDR20 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.